Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus Journal Article


Authors: Mullerad, M.; Eisenberg, D. P.; Akhurst, T. J.; Adusumilli, P. S.; Riedl, C. C.; Bhargava, A.; Gonen, M.; Finn, R.; Scardino, P. T.; Fong, Y.
Article Title: Use of positron emission tomography to target prostate cancer gene therapy by oncolytic herpes simplex virus
Abstract: Herpes simplex virus (HSV) oncolytic gene therapy is a promising treatment modality against cancer. We have demonstrated that androgen-induced cellular changes enhance oncolytic viral replication and improve efficacy in the treatment of androgen-dependent prostate cancer cell line. Imaging of changes in 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) uptake by positron emission tomography (PET) is a sensitive method of detecting altered cellular metabolism involved in cancer therapy. We therefore hypothesized that FDG-PET can predict tumor response to oncolytic HSV therapy. In this study, androgen increased cell kill (74%) in vitro and enhanced viral yield (2.4-fold) in vivo following HSV therapy. This enhanced efficacy was predicted by high FDG accumulation in intact animals compared to low FDG uptake following orchiectomy (p = 0.002). This proof-of-concept study provides the mechanistic basis for selecting patients for targeted oncolytic viral therapy by means of a noninvasive molecular imaging method in the treatment of prostate cancer. © Academy of Molecular Imaging 2005.
Keywords: controlled study; treatment outcome; treatment response; human cell; genetics; androgen; nonhuman; patient selection; positron emission tomography; antineoplastic agent; radiopharmaceuticals; mouse; animal; animals; mice; image analysis; animal experiment; animal model; in vivo study; cancer cell culture; in vitro study; molecular imaging; cell line, tumor; cancer therapy; prediction; physiology; animalia; prostate cancer; prostatic neoplasms; diagnostic agent; xenograft; nude mouse; mice, nude; prostate tumor; tumor cell line; rat; fluorodeoxyglucose f 18; fluorodeoxyglucose f18; positron-emission tomography; gene therapy; radiopharmaceutical agent; oncolytic virus; herpes virus; simplexvirus; transplantation, heterologous; radiosensitivity; hormonal therapy; virus replication; neoplasm transplantation; orchiectomy; herpes simplex virus; cell metabolism; non invasive measurement; fluorodeoxyglucose; cell killing; cancer transplantation; fluorine radioisotopes; fluorine; viral gene therapy
Journal Title: Molecular Imaging and Biology
Volume: 8
Issue: 1
ISSN: 1536-1632
Publisher: Springer  
Date Published: 2006-01-01
Start Page: 30
End Page: 35
Language: English
DOI: 10.1007/s11307-005-0028-x
PUBMED: 16362150
PROVIDER: scopus
PMCID: PMC1397882
DOI/URL:
Notes: --- - "Cited By (since 1996): 4" - "Export Date: 4 June 2012" - "CODEN: CPIMF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christopher Riedl
    60 Riedl
  2. Peter T Scardino
    671 Scardino
  3. Mithat Gonen
    1028 Gonen
  4. Ronald D Finn
    279 Finn
  5. Yuman Fong
    775 Fong
  6. Timothy J Akhurst
    139 Akhurst